BetterLife Pharma Inc.
BETR
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 71.26% | -217.50% | 141.91% | 26.73% | -48.70% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.53% | 5.98% | -287.36% | -80.92% | 180.40% |
| Change in Net Operating Assets | -66.79% | 817.73% | -230.55% | 125.81% | -203.95% |
| Cash from Operations | 25.93% | 87.02% | 85.78% | -15.55% | -234.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | 308.07% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 187.36% | -74.71% | -95.12% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Financing | 188.52% | -75.79% | -95.11% | -43.86% | 519.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 202.70% | 90.61% | 63.62% | -176.24% | 794.62% |